Choi Seung Il, Malik Shahbaz, MacLean Simon
Department of Orthopaedics, Tauranga Hospital, Christchurch, New Zealand.
NHS Trust, Worcestershire Acute Hospital, Worcester, United Kingdom.
J Wrist Surg. 2024 Apr 24;13(6):550-558. doi: 10.1055/s-0044-1786164. eCollection 2024 Dec.
Operative treatment of triangular fibrocartilage complex (TFCC) tears has been well researched; however, data regarding nonoperative management is mixed and scarce. Our review aimed to utilize available data to formulate conclusions regarding treatment algorithms for this heterogeneous injury group. A thorough literature review was performed in Medline (OVID), Embase, Cochrane Library, and PubMed databases with search terms including "triangular fibrocartilage complex" and variations on the full term including "triangular fibrocartilage" or "TFCC," alongside "non-operative" and "conservative." Results were then subject to inclusion criteria, ultimately identifying eight studies. The studies involved a total of 425 patients and 427 wrists for analysis. The mean age ranged from 30.7 years to 60.4 years. 53.6% of patients were male. The mean follow-up ranged from 12 months to 7 years, with an overall mean follow-up period of 27 months. Primary endpoints focused on various functional outcome scores, range of motion, grip strength, and pain. The nonoperative management of TFCC tears resulted in noninferior and comparable outcomes to operative management. Our review identified that the nonoperative management of Palmer-type IB tears with a short period of above-elbow immobilization was an effective treatment option with good functional outcome scores. The nonoperative management of general TFCC tears resulted in comparable functional outcomes when viewed alongside results from other systematic reviews. Risk factors for developing a poor functional outcome or requiring operative management included distal radioulnar joint subluxation, short-arm immobilization, and full tears of the foveal attachment. However, further randomized controlled trials with homogenous data collection are required to make further conclusions regarding the management of this condition.
三角纤维软骨复合体(TFCC)撕裂的手术治疗已得到充分研究;然而,关于非手术治疗的数据参差不齐且稀缺。我们的综述旨在利用现有数据,就这一异质性损伤组的治疗算法得出结论。
在Medline(OVID)、Embase、Cochrane图书馆和PubMed数据库中进行了全面的文献综述,搜索词包括“三角纤维软骨复合体”以及该术语的变体,如“三角纤维软骨”或“TFCC”,同时还有“非手术”和“保守”。然后对结果进行纳入标准筛选,最终确定了八项研究。
这些研究共涉及425例患者和427只手腕进行分析。平均年龄在30.7岁至60.4岁之间。53.6%的患者为男性。平均随访时间从12个月到7年不等,总体平均随访期为27个月。主要终点集中在各种功能结局评分、活动范围、握力和疼痛方面。TFCC撕裂的非手术治疗与手术治疗相比,结果不劣且相当。
我们的综述发现,对Palmer - IB型撕裂进行短期的肘部以上固定的非手术治疗是一种有效的治疗选择,功能结局评分良好。与其他系统综述的结果相比,一般TFCC撕裂的非手术治疗导致了相当的功能结局。功能结局不佳或需要手术治疗的危险因素包括桡尺远侧关节半脱位、短臂固定以及中央凹附着处的完全撕裂。然而,需要进一步进行数据收集同质化的随机对照试验,以就这种情况的治疗得出进一步结论。